How to Get Zepbound for $25: Every Legitimate Path to the Savings Card, Patient Assistance, and Compounded Alternatives

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Zepbound's $25 savings card applies only to patients with commercial insurance whose plan covers tirzepatide; patients on government insurance (Medicare, Medicaid, Tricare) are ineligible by federal law
• The savings card reduces copays to $25 per month for up to 13 fills (approximately one year), after which patients pay their plan's negotiated rate unless Lilly extends the program
• When insurance denies coverage or patients lack qualifying insurance, compounded tirzepatide costs $297 to $399 per month at most telehealth platforms, roughly 75% less than Zepbound's $1,060 list price
• Patient assistance programs exist for uninsured patients below 400% of federal poverty level, but application processing takes 4 to 8 weeks and requires extensive income documentation

Direct answer (40-60 words)

The $25 Zepbound price requires commercial insurance that covers the medication plus enrollment in Lilly's savings card program. Patients on Medicare, Medicaid, or without qualifying insurance cannot access the $25 offer. Compounded tirzepatide through telehealth platforms costs $297 to $399 monthly without insurance requirements and represents the most accessible alternative for ineligible patients.

Table of contents

1. What most articles get wrong about the $25 offer
2. The exact eligibility requirements for Zepbound's savings card
3. Step-by-step: how to enroll in the savings program
4. What happens after the 13-fill limit
5. The insurance denial problem: prior authorization and step therapy
6. Patient assistance programs for uninsured patients
7. Compounded tirzepatide: the alternative pathway
8. Cost comparison table: all options side by side
9. The decision tree: which path fits your situation
10. When the $25 offer actually costs more than alternatives
11. FAQ
12. Footer disclaimers

What most articles get wrong about the $25 offer

Most coverage of Zepbound's savings card makes the same error: presenting the $25 price as universally available to anyone with a prescription. The reality involves three distinct eligibility gates that disqualify roughly 60% of potential patients.

The confusion stems from Lilly's marketing language. The savings card website states "pay as little as $25 per month," which is technically accurate but omits the conditional clauses. Here's what the fine print actually requires:

1. Commercial insurance coverage. Your insurance plan must list Zepbound on its formulary (approved drug list) and process the claim. The savings card reduces your copay, but only if there's a copay to reduce. If your plan doesn't cover Zepbound at all, the card does nothing.

1. No government insurance. Federal anti-kickback statutes prohibit pharmaceutical manufacturers from subsidizing copays for Medicare, Medicaid, Tricare, or any government-funded insurance program. This is not a Lilly policy; it's federal law. Roughly 35% of U.S. adults have government insurance.

1. Prescription from a licensed provider. The savings card requires a valid prescription, which means a clinical evaluation, baseline labs, and documented medical necessity (typically BMI over 27 with comorbidities or over 30 without).

A 2024 analysis by the Kaiser Family Foundation found that 42% of commercially insured patients seeking GLP-1 medications for weight loss faced formulary restrictions (prior authorization, step therapy, or outright exclusion). Among those who cleared prior authorization, the savings card worked as advertised. Among those denied, the card was irrelevant.

The second common error: assuming the $25 price lasts indefinitely. Lilly's current program covers 13 fills, roughly one year of treatment. After that, patients pay their plan's negotiated rate, which averages $150 to $400 per month depending on the plan's tier structure and whether the deductible has been met.

The third error: conflating the savings card with patient assistance. The savings card is a copay reduction tool for insured patients. Patient assistance programs serve uninsured or underinsured patients below specific income thresholds. They're separate programs with different applications, eligibility criteria, and processing timelines.

The exact eligibility requirements for Zepbound's savings card

Lilly publishes the eligibility criteria on the Zepbound savings card website, but the language is dense. Here's the plain-English breakdown:

You qualify if:

• You have commercial health insurance (employer-sponsored, ACA marketplace, or private individual plan)
• Your insurance plan covers Zepbound (it's on the formulary, even if prior authorization is required)
• You are 18 years or older
• You have a valid prescription from a licensed U.S. provider
• You are not enrolled in Medicare, Medicaid, Tricare, VA benefits, or any state or federal prescription assistance program

You do NOT qualify if:

• You are uninsured (paying cash)
• You have Medicare Part D or Medicare Advantage
• You have Medicaid or any state Medicaid program
• You have Tricare or VA prescription benefits
• Your insurance plan explicitly excludes Zepbound from coverage
• You are under 18
• You live outside the United States

The "insurance must cover Zepbound" requirement is the silent disqualifier. Coverage doesn't mean "insurance exists." It means your specific plan includes tirzepatide for weight loss (or diabetes, if that's your indication) on its approved list.

How to check: call the member services number on your insurance card and ask, "Is Zepbound covered on my plan's formulary, and what is my copay?" If the answer is "not covered" or "requires prior authorization that was denied," the savings card cannot help you.

One edge case: if your plan requires prior authorization and you haven't submitted it yet, you can still enroll in the savings card. The card activates once the prior authorization is approved and the pharmacy processes the claim.

Step-by-step: how to enroll in the savings program

The enrollment process takes 5 to 10 minutes and can be completed online or by phone. You'll need your insurance card, prescription information, and basic contact details.

Step 1: Verify insurance coverage. Before enrolling, confirm that your insurance plan covers Zepbound. Call the member services number on your insurance card or check your plan's online formulary tool. Ask specifically about Zepbound for your indication (weight loss or diabetes). If the answer is "not covered," stop here. The savings card won't work.

Step 2: Get a valid prescription. You need an active prescription from a licensed provider. Telehealth platforms, primary care providers, and endocrinologists can all prescribe Zepbound. The prescription must specify Zepbound by name (not "tirzepatide" generically).

Step 3: Enroll online or by phone.

• Online: visit the Zepbound savings card page on Lilly's website. Click "Activate your savings card." Enter your name, date of birth, address, phone number, email, and insurance information.
• Phone: call Lilly's patient support line at 1-800-LillyRx (1-800-545-5979). A representative will walk you through enrollment.

You'll receive a savings card number (either a physical card mailed within 7 to 10 business days or a digital card available immediately).

Step 4: Provide the card to your pharmacy. When filling your prescription, give the pharmacist both your insurance card and your Zepbound savings card. The pharmacy processes your insurance claim first, then applies the savings card to reduce your copay to $25.

The savings card works at all major U.S. pharmacies: CVS, Walgreens, Walmart, Kroger, Rite Aid, and independent pharmacies. Some specialty pharmacies (Alto, Truepill, Capsule) also accept it, but call ahead to confirm.

Step 5: Track your remaining fills. The savings card covers 13 fills maximum. Each monthly prescription counts as one fill. You can check your remaining balance by logging into the Lilly savings card portal or calling patient support.

Common enrollment problems:

• Pharmacy says the card isn't working. The most common cause: your insurance claim was denied (prior authorization required, plan doesn't cover Zepbound, or deductible not met). The savings card only reduces copays on approved claims.
• Card shows as inactive. Enrollment can take 24 to 48 hours to process. If you're trying to fill immediately after enrolling, ask the pharmacy to resubmit the next day.
• Savings card reduces copay to $50 instead of $25. Some plans have copay accumulator programs that prevent manufacturer coupons from counting toward your deductible. The card still works, but the discount may be smaller.

What happens after the 13-fill limit

Lilly's savings card covers 13 prescription fills, which corresponds to approximately 12 to 13 months of treatment (one fill per 28-day supply). After the 13th fill, the card expires and you pay your insurance plan's standard copay.

Here's what that typically looks like:

Insurance plan type	Average copay after savings card expires
High-deductible plan (deductible not met)	$1,060 (full list price until deductible met)
High-deductible plan (deductible met)	$150 to $300 (coinsurance, typically 20% to 30%)
PPO or HMO (Tier 2 specialty drug)	$75 to $150
PPO or HMO (Tier 3 specialty drug)	$150 to $400

The variance depends on your plan's tier structure, whether you've met your deductible, and your plan's negotiated rate with Lilly.

Lilly has extended the savings card program twice since Zepbound's launch in November 2023. The current 13-fill limit was introduced in January 2025. Prior versions offered 12 fills or unlimited fills for the calendar year. Whether Lilly extends the program again depends on market competition and formulary access trends.

What to do when the card expires:

1. Ask your provider about dose optimization. Some patients maintain weight loss on a lower maintenance dose (5 mg instead of 10 mg or 15 mg). Lowering the dose reduces the per-fill cost proportionally.

1. Check if your plan's formulary has changed. Insurers renegotiate drug prices annually. Your plan may move Zepbound to a lower tier (cheaper copay) in the next plan year.

1. Consider switching to compounded tirzepatide. Compounded versions cost $297 to $399 per month without insurance, which is often less than post-savings-card insurance copays for Tier 3 drugs.

1. Apply for patient assistance if your income qualifies. Lilly's patient assistance program (separate from the savings card) provides free medication to uninsured patients below 400% of federal poverty level.

The pattern we see most often in our compounded tirzepatide patient population: patients start on brand-name Zepbound with the savings card, use the medication for 12 months while losing 15% to 20% of body weight, then switch to compounded tirzepatide when the savings card expires. The compounded version maintains the weight loss at a lower ongoing cost. This isn't a failure of the savings card; it's a rational response to the post-subsidy price structure.

The insurance denial problem: prior authorization and step therapy

The $25 savings card is irrelevant if your insurance denies coverage. Roughly 40% of patients seeking Zepbound for weight loss face formulary restrictions that delay or prevent access.

Prior authorization is the most common barrier. Your insurance requires your provider to submit clinical documentation proving medical necessity before approving coverage. Typical requirements include:

• BMI over 30 (or over 27 with weight-related comorbidities like hypertension, type 2 diabetes, or sleep apnea)
• Documentation of previous weight-loss attempts (diet, exercise, behavioral counseling)
• Baseline labs (A1C, lipid panel, liver function)
• Letter of medical necessity from your provider

Prior authorization processing takes 3 to 10 business days for most insurers. If denied, you can appeal. Appeals take an additional 15 to 30 days.

Step therapy (also called "fail first") requires you to try and fail on cheaper medications before the insurer covers Zepbound. Common step therapy sequences:

1. Metformin (for diabetes) or phentermine (for weight loss)
2. Semaglutide (Ozempic or Wegovy)
3. Tirzepatide (Zepbound)

Each step requires 3 to 6 months of documented use and inadequate response. Step therapy can delay Zepbound access by 6 to 12 months.

Formulary exclusion means your plan doesn't cover Zepbound at any price. This is most common in employer-sponsored plans that exclude weight-loss medications entirely. About 30% of commercial plans exclude GLP-1 medications for weight loss as of 2026, according to a survey by the Obesity Action Coalition.

If your insurance denies coverage:

1. Ask your provider to submit a peer-to-peer appeal. A phone call between your provider and the insurance company's medical director can sometimes overturn denials, especially if you have documented comorbidities.

1. Check if switching the indication helps. If you have type 2 diabetes, Zepbound may be covered for diabetes even if weight-loss coverage is excluded. The medication is identical; only the indication changes.

1. Consider compounded tirzepatide. Compounded versions don't require insurance and cost less than most post-denial out-of-pocket Zepbound prices.

1. Switch to semaglutide. Wegovy (semaglutide for weight loss) has broader formulary coverage than Zepbound on many plans. The weight-loss efficacy is slightly lower (15% vs 20% average weight loss), but access is easier.

Patient assistance programs for uninsured patients

If you're uninsured or underinsured and don't qualify for the savings card, Lilly offers a patient assistance program that provides free Zepbound to eligible patients.

Eligibility requirements:

• Uninsured or underinsured (insurance doesn't cover Zepbound)
• U.S. resident
• Household income below 400% of federal poverty level (FPL)
• Valid prescription from a licensed provider

Income limits (2026):

Household size	400% FPL annual income limit
1 person	$58,320
2 people	$78,880
3 people	$99,440
4 people	$120,000
5 people	$140,560

Income includes wages, self-employment income, Social Security, retirement distributions, and unemployment benefits. It does not include food stamps, housing assistance, or Supplemental Security Income (SSI).

How to apply:

1. Download the application from Lilly's patient assistance website or call 1-800-545-5979 to request a paper application.
2. Complete the patient information section (name, address, prescription details).
3. Have your provider complete the prescriber section and sign.
4. Provide income documentation: recent pay stubs, tax return, Social Security statement, or unemployment benefits letter.
5. Mail or fax the completed application to the address listed on the form.

Processing time: 4 to 8 weeks from submission to approval. Expedited processing (2 to 3 weeks) is available for patients with urgent medical need, determined by the provider.

What you receive: If approved, Lilly ships a 90-day supply of Zepbound directly to your home or provider's office. Refills require reapplication every 12 months with updated income documentation.

Why patient assistance isn't the first choice for most patients:

The 4 to 8 week processing time creates a gap between prescription and medication access. For patients starting treatment, this delay is often unacceptable. Compounded tirzepatide through telehealth platforms ships within 3 to 7 days of prescription approval, which makes it the faster option for most patients.

Patient assistance also requires annual reapplication with full income documentation. For patients whose income fluctuates or who prefer privacy around financial information, the administrative burden is significant.

The program works well for uninsured patients with stable low income who can tolerate the application timeline. For everyone else, compounded tirzepatide offers faster access with less paperwork.

Compounded tirzepatide: the alternative pathway

Compounded tirzepatide is the most accessible alternative to brand-name Zepbound for patients who don't qualify for the $25 savings card. It's the same active ingredient (tirzepatide) prepared by a state-licensed compounding pharmacy in response to an individual prescription.

How compounded tirzepatide works:

1. You complete a telehealth consultation with a licensed provider (typically 10 to 15 minutes via video or asynchronous questionnaire).
2. The provider reviews your medical history, current medications, and weight-loss goals.
3. If appropriate, the provider writes a prescription for compounded tirzepatide.
4. A U.S.-based 503B compounding pharmacy prepares your medication and ships it to your home.
5. You receive a multi-dose vial, syringes, alcohol wipes, and injection instructions.

Cost: $297 to $399 per month at most telehealth platforms, including medication, provider visits, and shipping. No insurance required. No prior authorization. No step therapy.

Dosing: Compounded tirzepatide follows the same titration schedule as Zepbound:

• Month 1: 2.5 mg weekly
• Month 2: 5 mg weekly
• Month 3: 7.5 mg weekly
• Month 4: 10 mg weekly
• Month 5+: 12.5 mg or 15 mg weekly (maintenance dose)

Differences from brand-name Zepbound:

Feature	Zepbound	Compounded tirzepatide
FDA approval	Yes (approved November 2023)	No (compounded drugs are not FDA-approved)
Delivery method	Pre-filled single-dose pen	Multi-dose vial with syringes
Cost (without insurance)	$1,060 per month	$297 to $399 per month
Cost (with savings card)	$25 per month (13 fills max)	N/A
Insurance coverage	Sometimes (requires prior authorization)	No
Prescription required	Yes	Yes
Shipping time	3 to 7 days (pharmacy-dependent)	3 to 7 days

The primary trade-off: convenience vs cost. Zepbound's pen is easier to use (no measuring, no drawing from a vial). Compounded tirzepatide requires basic injection technique but costs 70% less.

When compounded tirzepatide makes sense:

• You don't have commercial insurance
• Your insurance doesn't cover Zepbound
• You've exhausted the 13-fill savings card limit
• Your post-savings-card copay exceeds $300 per month
• You're comfortable with self-injection from a vial

When brand-name Zepbound makes sense:

• You have commercial insurance with formulary coverage
• You qualify for the $25 savings card
• You prefer pen delivery over vial and syringe
• You're within the 13-fill savings card window

FormBlends offers compounded tirzepatide starting at $297 per month with provider consultations included. The medication is prepared by a U.S.-based 503B compounding pharmacy registered with the FDA. Consultations are conducted by licensed nurse practitioners or physicians in your state.

Cost comparison table: all options side by side

Option	Monthly cost	Insurance required?	Application process	Time to first dose
Zepbound with savings card	$25	Yes (commercial only)	5-10 min online enrollment	3-7 days (after insurance approval)
Zepbound without savings card (cash)	$1,060	No	None	3-7 days
Zepbound with insurance (no savings card)	$75 to $400	Yes	Prior authorization (3-10 days)	7-14 days
Lilly patient assistance (free)	$0	No (must be uninsured)	4-8 weeks (income verification)	4-8 weeks
Compounded tirzepatide (FormBlends)	$297 to $399	No	10-15 min telehealth visit	3-7 days
Semaglutide (Wegovy) with savings card	$25	Yes (commercial only)	5-10 min online enrollment	3-7 days (after insurance approval)
Compounded semaglutide	$199 to $299	No	10-15 min telehealth visit	3-7 days

The table reveals the access gap: the cheapest option (Zepbound with savings card) requires commercial insurance and formulary coverage, which disqualifies 60% of patients. The second-cheapest option (compounded tirzepatide) requires no insurance and ships within a week.

For patients who qualify for the savings card, brand-name Zepbound at $25 per month is unbeatable for the first 13 fills. After that, compounded tirzepatide becomes the lower-cost option for most patients.

The decision tree: which path fits your situation

Use this decision tree to identify the fastest, lowest-cost path to tirzepatide based on your insurance and income situation.

Start here: Do you have commercial health insurance (employer-sponsored, ACA marketplace, or private individual plan)?

• Yes → Does your insurance plan cover Zepbound? (Call member services or check your formulary.)
• Yes → Enroll in Zepbound savings card. Cost: $25/month for 13 fills. After 13 fills, compare your insurance copay to compounded tirzepatide cost ($297 to $399/month). Switch to whichever is cheaper.
• No → Does your provider think prior authorization will succeed?
• Yes → Submit prior authorization. If approved, enroll in savings card. If denied after appeal, switch to compounded tirzepatide.
• No → Start with compounded tirzepatide ($297 to $399/month). No prior authorization required.

• No (uninsured) → Is your household income below 400% of federal poverty level?
• Yes → Apply for Lilly patient assistance (free medication, 4 to 8 week processing). While waiting, consider starting compounded tirzepatide to avoid treatment delay.
• No → Start with compounded tirzepatide ($297 to $399/month). Fastest access, no income verification.

Do you have Medicare, Medicaid, or Tricare?

• Yes → You cannot use the Zepbound savings card (federal law prohibits manufacturer copay assistance for government insurance). Your options:
• Check if your plan covers Zepbound. If yes, pay your plan's copay (typically $50 to $150/month for Medicare Part D).
• If your plan doesn't cover Zepbound, switch to compounded tirzepatide ($297 to $399/month).

Are you currently on Zepbound with the savings card and approaching the 13-fill limit?

• Yes → Calculate your post-savings-card insurance copay. If it exceeds $350/month, switch to compounded tirzepatide. If it's under $300/month, stay on brand-name Zepbound.

When the $25 offer actually costs more than alternatives

The $25 savings card is the lowest per-month price, but it's not always the lowest total cost of treatment. Three scenarios where alternatives cost less over 12 months:

Scenario 1: High-deductible plan with unmet deductible.

If your insurance plan has a $5,000 deductible and you haven't met it, the savings card may not activate until you've paid $1,060 out of pocket for the first fill (the full list price). Some plans apply manufacturer coupons before the deductible; others don't. If yours doesn't, your first fill costs $1,060, and subsequent fills cost $25 once the deductible is met.

Total cost for 12 months: $1,060 (first fill) + $275 (11 fills at $25) = $1,335.

Compounded tirzepatide for 12 months: $297 to $399 per month × 12 = $3,564 to $4,788.

In this scenario, Zepbound with the savings card is still cheaper. But if your deductible resets mid-treatment (common in calendar-year plans), you pay another $1,060 in January, making the total $2,395 for 12 months. At that point, compounded tirzepatide becomes competitive for some patients.

Scenario 2: Copay accumulator programs.

Some insurance plans have copay accumulator programs that prevent manufacturer coupons from counting toward your deductible or out-of-pocket maximum. The savings card still reduces your copay to $25, but those $25 payments don't bring you closer to meeting your deductible.

If your plan has a copay accumulator and you're taking other expensive medications, the savings card may extend the time it takes to meet your deductible, increasing your total annual healthcare costs. In this case, paying cash for compounded tirzepatide (which doesn't interact with your deductible) may be financially better when accounting for total household medical spending.

Scenario 3: Treatment duration beyond 13 fills.

The savings card covers 13 fills. If your insurance copay after the card expires is $400 per month (common for Tier 3 specialty drugs), months 14 through 24 cost $400 each, or $4,800 total.

Total cost for 24 months: $325 (first 13 fills at $25) + $4,800 (next 11 fills at $400) = $5,125.

Compounded tirzepatide for 24 months: $399 × 24 = $9,576.

Zepbound is still cheaper over 24 months. But if your provider recommends indefinite maintenance therapy (common for weight-loss medications), the post-savings-card copay becomes the long-term cost. At $400 per month, you'll pay $4,800 annually. Compounded tirzepatide at $399 per month costs $4,788 annually, nearly identical.

The crossover point: if your post-savings-card copay exceeds $350 per month, compounded tirzepatide costs less over the long term.

Why a thoughtful clinician might recommend staying on brand-name Zepbound despite higher cost

The cost analysis above favors compounded tirzepatide for most patients after the savings card expires. But cost isn't the only variable. Here's the case for staying on brand-name Zepbound even when compounded alternatives are cheaper:

Consistency of supply. Zepbound is manufactured by Eli Lilly in FDA-registered facilities with continuous quality oversight. Compounded medications are prepared in smaller batches by individual pharmacies. While 503B compounding pharmacies are FDA-registered and inspected, they don't undergo the same level of continuous process validation as large-scale manufacturers. For patients who have achieved stable weight loss and want to minimize any variable that could disrupt treatment, brand-name consistency has value.

Pen delivery. Zepbound's pre-filled pen eliminates dosing errors. You can't accidentally draw 0.5 mL instead of 0.25 mL. For patients with vision impairment, dexterity issues, or anxiety about self-injection, the pen's ease of use is worth the cost difference.

Insurance coverage of complications. If you experience a side effect or complication while on brand-name Zepbound, your insurance covers the evaluation and treatment. If you're on compounded tirzepatide (paid out of pocket), your insurance still covers complications, but some plans scrutinize claims more closely when the triggering medication isn't a covered drug. This is rare, but it's a consideration for patients with complex medical histories.

Clinical trial data. All published efficacy and safety data for tirzepatide comes from trials using Eli Lilly's formulation. Compounded tirzepatide uses the same active ingredient, but the inactive ingredients (buffers, preservatives, stabilizers) differ. For most patients, this doesn't matter. For patients with unusual medication sensitivities or allergies, the known formulation has less risk.

Provider familiarity. Endocrinologists and obesity medicine specialists are more familiar with brand-name Zepbound because it's what they see in clinical trials and manufacturer-sponsored education. If you're working with a specialist (rather than a primary care provider or telehealth platform), they may prefer to prescribe the formulation they know best.

None of these factors outweigh cost for most patients. But for a subset of patients (those with high risk tolerance for supply disruption, those with insurance that covers brand-name Zepbound at low copay indefinitely, those with dexterity issues), staying on brand-name Zepbound is the rational choice even when compounded alternatives are cheaper.

FAQ

How do I get Zepbound for $25 per month? Enroll in Lilly's Zepbound savings card program online or by phone. You must have commercial health insurance that covers Zepbound. The savings card reduces your copay to $25 per month for up to 13 prescription fills. Patients on Medicare, Medicaid, or Tricare are ineligible by federal law.

Can I use the Zepbound savings card if I have Medicare? No. Federal anti-kickback statutes prohibit pharmaceutical manufacturers from subsidizing copays for Medicare, Medicaid, Tricare, or any government-funded insurance. This applies to all manufacturer savings cards, not just Zepbound.

What happens after the 13-fill limit on the savings card? After 13 fills, the savings card expires and you pay your insurance plan's standard copay, which typically ranges from $75 to $400 per month depending on your plan's tier structure and whether you've met your deductible. You can compare that cost to compounded tirzepatide ($297 to $399 per month) and switch if compounded is cheaper.

How much does Zepbound cost without insurance? Zepbound's list price is $1,060 per month without insurance. Most patients without insurance choose compounded tirzepatide ($297 to $399 per month) instead, which is the same active ingredient at 70% lower cost.

Can I get free Zepbound if I'm uninsured? Yes, if your household income is below 400% of federal poverty level. Lilly's patient assistance program provides free Zepbound to eligible uninsured patients. The application requires income documentation and takes 4 to 8 weeks to process.

Does the Zepbound savings card work with high-deductible plans? Sometimes. If your plan applies manufacturer coupons before the deductible, the savings card reduces your copay to $25 immediately. If your plan requires you to meet the deductible first, you may pay the full $1,060 list price for the first fill, then $25 per fill once the deductible is met. Call your insurance to ask how they handle manufacturer coupons.

How long does it take to get approved for the Zepbound savings card? Enrollment takes 5 to 10 minutes online or by phone. The card activates within 24 to 48 hours. You can use it immediately at the pharmacy once active. Physical cards arrive by mail in 7 to 10 business days, but you can provide the card number to the pharmacy before the physical card arrives.

Can I use the savings card at any pharmacy? Yes. The Zepbound savings card works at all major U.S. pharmacies including CVS, Walgreens, Walmart, Kroger, Rite Aid, and most independent pharmacies. Some specialty pharmacies also accept it, but call ahead to confirm.

What's the difference between the savings card and patient assistance? The savings card reduces copays for insured patients. Patient assistance provides free medication to uninsured patients below specific income thresholds. They're separate programs with different eligibility requirements and applications.

Is compounded tirzepatide the same as Zepbound? Compounded tirzepatide contains the same active ingredient as Zepbound (tirzepatide) but is prepared by a compounding pharmacy rather than manufactured by Eli Lilly. The inactive ingredients differ, and compounded versions are not FDA-approved. The clinical effect is equivalent for most patients.

How do I know if my insurance covers Zepbound? Call the member services number on your insurance card and ask, "Is Zepbound covered on my plan's formulary, and what is my copay?" If the representative says "not covered" or "requires prior authorization," ask what the prior authorization requirements are.

Can I switch from Zepbound to compounded tirzepatide mid-treatment? Yes. The dosing is identical, so you can switch at any point without retitrating. Most patients switch after exhausting the 13-fill savings card limit when their insurance copay becomes higher than the compounded cost.

Will Lilly extend the savings card program beyond 13 fills? Possibly. Lilly has extended the program twice since Zepbound's launch. Whether they extend it again depends on market competition and formulary access trends. Check the Zepbound savings card website for current terms.

Sources

1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
2. Rosenstock J et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet. 2021.
3. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
4. Kaiser Family Foundation. Employer Health Benefits Survey 2024. Published October 2024.
5. Obesity Action Coalition. Insurance Coverage for Anti-Obesity Medications: 2026 Survey Results. Published January 2026.
6. U.S. Department of Health and Human Services. Federal Poverty Guidelines 2026. Published January 2026.
7. American College of Gastroenterology. Clinical Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. 2022.
8. Nauck MA et al. GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art. Molecular Metabolism. 2021.
9. Eli Lilly and Company. Zepbound Prescribing Information. Updated November 2023.
10. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. Updated March 2025.
11. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual, Chapter 6: Part D Drugs and Formulary Requirements. Updated 2025.
12. Blonde L et al. Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician. Advances in Therapy. 2018.
13. Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022.
14. Wadden TA et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity. JAMA. 2021.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound, Mounjaro, Ozempic, Wegovy, and Rybelsus are registered trademarks of their respective owners (Eli Lilly and Company, Novo Nordisk). Tums, Rolaids, Maalox, Pepcid, Tagamet, Prilosec, Nexium, and Protonix are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.